Basics Apogee Therapeutics, Inc. IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $2.17B Activated in VL: True Average Daily Range Avg Daily Range: $1.12 | 2.89% Avg Daily Range (30 D): $1.19 | 2.82% Avg Daily Range (90 D): $1.08 | 2.86% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .96M Avg Daily Volume (90 D): .69M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 57 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 1,028 Avg Inst. Trade: $2.67M Avg Inst. Trade (30 D): $2.26M Avg Inst. Trade (90 D): $2.5M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.8M Avg Closing Trade (30 D): $5.21M Avg Closing Trade (90 D): $4.28M Avg Closing Volume: 88.14K     News Jul 7, 2025 @ 10:00 AM Apogee Therapeutics Announces Positive 16-Week Dat... Source: Apogee Therapeutics Jul 6, 2025 @ 10:00 PM Apogee Therapeutics to Host Conference Call to Rep... Source: Apogee Therapeutics, Inc. May 12, 2025 @ 10:00 AM Apogee Therapeutics Announces Positive Interim Res... Source: N/A May 1, 2025 @ 12:00 PM Apogee Therapeutics to Participate at the Bank of ... Source: N/A Mar 3, 2025 @ 11:00 AM Apogee Therapeutics Announces Positive Interim Pha... Source: Apogee Therapeutics, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.95 $-.86 $-.6 Diluted EPS $-.95 $-.86 $-.6 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -55.34M $ -49.02M $ -33.82M Operating Income / Loss $ -63.1M $ -58.69M $ -44.12M Cost of Revenue $ $ $ Net Cash Flow $ -34.87M $ -188.52M $ -178.16M PE Ratio     Splits Jan 08, 2008:   1:50